Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Thrombocytopenia(ITP)”

546 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 546 results

Not applicableStudy completedNCT06408324
What this trial is testing

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
European Research Consortium on ITP 275
Testing effectiveness (Phase 2)UnknownNCT01162941
What this trial is testing

Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)

Who this might be right for
Thrombocytopenia
Cooperative Study Group A for Hematology 38
Post-approval studies (Phase 4)UnknownNCT05311930
What this trial is testing

Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 69
Testing effectiveness (Phase 2)Study completedNCT00111475
What this trial is testing

Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Amgen 45
Post-approval studies (Phase 4)Study completedNCT00467571
What this trial is testing

Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura

Who this might be right for
Chronic Idiopathic Thrombocytopenic PurpuraHelicobacter Pylori Infection
Mahidol University 26
Large-scale testing (Phase 3)Study completedNCT04516967
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 75
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Not applicableStudy completedNCT01719692
What this trial is testing

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
Institute of Hematology & Blood Diseases Hospital, China 100
Testing effectiveness (Phase 2)Study completedNCT04812483
What this trial is testing

Immunomodulation With Eltrombopag in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
University Children's Hospital Basel 2
Testing effectiveness (Phase 2)Ended earlyNCT00547066
What this trial is testing

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Autoimmune
Gilead Sciences 48
Post-approval studies (Phase 4)UnknownNCT05522465
What this trial is testing

Short-course High-dose Prednisone and Dexamethasone in Children With ITP

Who this might be right for
Immune ThrombocytopeniaGlucocorticoidsChild, Only
Fujian Medical University Union Hospital 608
Large-scale testing (Phase 3)Study completedNCT02279173
What this trial is testing

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Amgen 203
Early research (Phase 1)Not Yet RecruitingNCT07315373
What this trial is testing

Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Large-scale testing (Phase 3)UnknownNCT04915482
What this trial is testing

TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune Thrombocytopenia (ITP)AutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 94
Testing effectiveness (Phase 2)Study completedNCT02273960
What this trial is testing

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Bristol-Myers Squibb 46
Large-scale testing (Phase 3)Ended earlyNCT01433978
What this trial is testing

A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07710248
What this trial is testing

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

Who this might be right for
Primary Immune Thrombocytopenia
Hangzhou Sumgen Biotech Co., Ltd. 60
Not applicableLooking for participantsNCT06715215
What this trial is testing

Role of Acute Phase Proteins In Diagnosis of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Sohag University 100
Early research (Phase 1)Study completedNCT03603132
What this trial is testing

Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 15
Next Page